
Deciphex is building a global network of AI empowered pathologists, ensuring accessible, innovative pathology services that improve patient outcomes. The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload. We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.

Deciphex is building a global network of AI empowered pathologists, ensuring accessible, innovative pathology services that improve patient outcomes. The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload. We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.
Headquarters: Glasnevin, Dublin, Ireland
Founded: 2017
Core product areas: Diagnexia (clinical diagnostics network), Patholytix (digital pathology workflows & AI)
Latest disclosed round: €31M Series C (Jan 2025)
Total funding (reported): USD 78,100,000 (reported)
Digital pathology and AI-enabled diagnostic workflows to scale pathology services and support clinical/research needs.
2017
Software Development
€31,000,000
Announced Jan 2025; participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, MedTech Syndicates and NextSteps Capital.
$11,500,000
Announced May 2022; participation from Charles River Laboratories, Novartis, IRRUS Investments, NextSteps Capital and others.
“Molten Ventures led Series C; participation from strategic and life-science investors including ACT Venture Capital, Seroba Life Sciences, Charles River Laboratories and others.”
| Company |
|---|
Lab-Based – Kidlington, Oxford, UK (OX5 ILH)
Shifts That Work Around You
Diagnexia, a subsidiary of Deciphex: Accelerating Certainty and Pioneering Pathology Services.
We're transforming how pathology works. Since our parent company Deciphex was founded in Dublin in 2017, we've grown into a global team of over 230 professionals with offices across Dublin, Exeter, Oxford and Chicago.
Our mission is simple but vital - accelerate drug development and deliver faster, more accurate cancer diagnoses. Through our cloud-based platform, hospitals worldwide can instantly connect with our expert subspecialists for rapid case consultations.
At Diagnexia, you'll be part of pioneering digital pathology solutions that directly improve patient outcomes and keep healthcare organisations at the cutting edge of diagnostic innovation.
Why Senior Biomedical Scientists Join Diagnexia
Bring your HCPC-registered expertise to a team that values precision and impact.
How you’ll thrive with us
At Diagnexia, we’re building the future of digital pathology.
About The Role
What You’ll help us achieve
What You’ll Bring
Note: This job description is not exhaustive but an indication of the type and range of tasks that are expected of the postholder, and other duties may be required, in line with the role. A full job description will be made available before the interview.
Diagnexia is an equal opportunities employer and we are committed to the principle of equality. All qualified applicants will be considered for employment without regard to age, race, religious beliefs, political views, gender identity, affectional or sexual orientation, national origin, family or marital status including pregnancy, disability, membership of the travelling community or any other classification protected by applicable law.
A copy of our privacy policy can be viewed here